Weighing Standard Ensures USP Compliance - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Weighing Standard Ensures USP Compliance


Mettler Toledo’s global weighing standard, GWP, can help pharmaceutical manufacturers and suppliers meet the new requirements of United States Pharmacopeia’s (USP) revised Chapter 41 on balances and updates to the advisory Chapter 1251. The new revisions define modified balance test procedures for the US pharmaceutical industry and also apply to companies exporting to the US. The revised chapters become official on Dec. 1, 2013.

The revised General Chapter 41 details a relatively demanding balance assessment, outlining accuracy and repeatability tests for calibrated balances used to weigh analytes for quantitative measures. Since accuracy can only be gauged using weights that are at least 5% of an instrument’s capacity, test weight selection criteria have also been modified accordingly (weights smaller than 5% cannot assess systematic deviations sufficiently well enough).

General Chapter 1251 provides additional clarification on the new procedures and extends the scope to any balance used for an analytical procedure. It details that balance performance verification should be carried out using a risk-based approach. It is recommended to only weigh net samples that weigh sufficiently more than the minimum weight to account for fluctuations in the balance's performance due to varying influences from the environment and the balance operators. This requirement is clearly applied to the sample weight itself—and not to the tare vessel. Daily testing recommendations have been dropped, a change that is expected to provide significant time savings, according to a Mettler Toledo statement.

Mettler Toledo’s GWP Verification is standardized scientific methodology for secure selection, calibration and operation of weighing equipment. It provides the documented evidence for reproducible weighing results in harmony with all current quality standards in laboratory and manufacturing. Users can use GWP as the benchmark to select and calibrate their weighing equipment.

The company offers a free on-demand webinar that explains how balance quality management will be affected, focusing on the determination of minimum weight and execution of routine testing. A free white paper, video, and e-learning course are offered.

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerTargeting Different Off-Shore Destinations
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAsymmetric Synthesis Continues to Advance
Jill Wechsler Regulatory Watch Jill Wechsler Data Integrity Key to GMP Compliance
Sean Milmo European Regulatory WatchSean MilmoExtending the Scope of Pharmacovigilance Comes at a Price
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes

Click here